Earnings History Data for Pyxis Oncology (PYXS) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Pyxis Oncology

Pyxis Oncology Inc. is a preclinical oncology company. It focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers. The company's product pipeline includes antibody drug conjugate and monoclonal antibody. Pyxis Oncology Inc. is based in CAMBRIDGE, Mass.

Release Date	Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
21-03-2024	PM	PYXS	Pyxis Oncology	228.00	-0.33	-0.49	0.00	Pyxis Oncology GAAP EPS of -$1.85 beats by $0.10 [3/21/2024 11:32 AM]	4.98	-0.45 (-8.29%)	5.00	-0.43 (-7.92%)	1.35 - 6.92	2,439,035	660,000	57,917
Pyxis Oncology GAAP EPS of -$1.85 beats by $0.10 [3/21/2024 11:32 AM]
11-08-2023	PM	PYXS	Pyxis Oncology	93.00	-0.41	-0.66	0.00	Pyxis Oncology GAAP EPS of -$0.41 [8/11/2023 10:25 AM]	2.57	0.15 (6.20%)	0.0	0.0 (0.00%)	1.10 - 6.92	294,325	170,000	0
Pyxis Oncology GAAP EPS of -$0.41 [8/11/2023 10:25 AM]
11-05-2023	PM	PYXS	Pyxis Oncology	104.00	-0.54	-0.84	0.00	Pyxis Oncology GAAP EPS of -$0.54 beats by $0.39 [5/11/2023 10:02 AM]	3.04	0.06 (2.18%)	2.98	0.0 (0.00%)	1.10 - 6.92	666,579	470,000	2,296
Pyxis pancreatic cancer candidate PYX-201 given Orphan Drug status [5/11/2023 9:59 AM] Pyxis Oncology GAAP EPS of -$0.54 beats by $0.39 [5/11/2023 10:02 AM]
22-03-2023	PM	PYXS	Pyxis Oncology	83.00	-1.04	-0.85	0.00	Pyxis Oncology GAAP EPS of -$3.65 beats by $0.08 [3/22/2023 8:08 AM]	2.18	-0.02 (-0.91%)	2.27	0.07 (3.18%)	1.10 - 5.31	961,245	150,000	391,035
Pyxis Oncology GAAP EPS of -$3.65 beats by $0.08 [3/22/2023 8:08 AM] Pyxis Oncology gains as Pfizer raises stake [3/22/2023 8:42 AM]
01-11-2022	PM	PYXS	Pyxis Oncology	62.00	-0.85	-0.76	0.00	Pyxis Oncology GAAP EPS of -$0.85 misses by $0.03 [11/1/2022 8:04 AM]	1.71	-0.16 (-8.82%)	0.0	0.0 (0.00%)	1.49 - 14.00	96,030	70,000	0
Pyxis Oncology GAAP EPS of -$0.85 misses by $0.03 [11/1/2022 8:04 AM] Pyxis Oncology Reports Financial Results for the Quarter Ended September 30, 2022 and Provides Corporate Update [Nov-01-22 06:30AM]
13-05-2022	PM	PYXS	Pyxis Oncology	70.00	-0.97	-0.62	0.00		2.10	-0.11 (-5.18%)	2.22	0.0 (0.00%)	2.00 - 19.00	479,033	260,000	455
Pyxis Oncology Reports Financial Results for the Quarter Ended March 31, 2022 and Provides Business Update [May-13-22 08:03AM]
29-03-2022	PM	PYXS	Pyxis Oncology, Inc.	154.97	N/A	-0.34	0.00	Pyxis Oncology GAAP EPS of -$8.95 misses by $5.88 [3/29/2022 7:12 AM]	4.85	0.0 (0.00%)	4.75	0.05 (1.06%)	4.13 - 19.00	282,114	80,000	731
Pyxis Oncology GAAP EPS of -$8.95 misses by $5.88 [3/29/2022 7:12 AM] Pyxis Oncology to pay $10M upfront to license Biosion's antibody BSI-060T [3/29/2022 12:52 PM] Pyxis Oncology Provides Corporate and Financial Update [Mar-29-22 06:35AM] Biosion licenses BSI-060T (anti-Siglec-15) to Pyxis Oncology [Mar-29-22 11:00AM]